US 11279933
Antisense oligonucleotides for the treatment of leber congenital amaurosis
granted A61PA61P27/02
Quick answer
US patent 11279933 (Antisense oligonucleotides for the treatment of leber congenital amaurosis) held by Stichting Radboud universitair medisch centrum expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Stichting Radboud universitair medisch centrum
- Grant date
- Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P27/02